Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Inventory (2016 - 2025)

Historic Inventory for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $43.0 million.

  • Aspen Aerogels' Inventory fell 926.21% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 926.21%. This contributed to the annual value of $47.6 million for FY2024, which is 2133.76% up from last year.
  • Per Aspen Aerogels' latest filing, its Inventory stood at $43.0 million for Q3 2025, which was down 926.21% from $52.1 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Inventory ranged from a high of $56.7 million in Q1 2025 and a low of $9.4 million during Q2 2021
  • Its 5-year average for Inventory is $31.4 million, with a median of $33.3 million in 2023.
  • Per our database at Business Quant, Aspen Aerogels' Inventory crashed by 1924.51% in 2021 and then soared by 11210.87% in 2022.
  • Quarter analysis of 5 years shows Aspen Aerogels' Inventory stood at $12.0 million in 2021, then skyrocketed by 88.02% to $22.5 million in 2022, then soared by 73.88% to $39.2 million in 2023, then rose by 21.34% to $47.6 million in 2024, then fell by 9.49% to $43.0 million in 2025.
  • Its Inventory stands at $43.0 million for Q3 2025, versus $52.1 million for Q2 2025 and $56.7 million for Q1 2025.